You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華檢醫療(01931.HK)收購國富量子20.31%股權,推進RWA交易所戰略持續落地

華檢醫療(01931.HK)公佈,2025年9月1日,公司擬收購國富量子(00290.HK)20.31%股權,代價為約31.42億港元,代價將通過公司按每股9.69港元發行3.24億股份代價股份予以支付。完成後,公司將成為國富量子(00290.HK)的控股股東。

據悉,國富量子作為立足香港、依託大灣區、面向國際的全牌照科技金融平台,已在量子計算、人工智能與區塊鏈融合領域積累豐富資源,並聯合發起"香港數字資產上市公司聯合會",提出"五位一體"的RWA發展戰略。其目前已與京北方、金湧投資、貝瑞基因等多家企業達成合作,未來將協同公司進一步拓展資產類型與合作路徑,加快RWA生態建設與項目落地。

公吿顯示,此次收購國富量子20.31%的股份,是集團推進RWA交易所戰略持續落地、實現生態協同的重要舉措,具有深遠的產業意義和資本價值。

此次收購完成後,華檢醫療將藉助國富量子持有的南方東英22.5%股權資源,協同構建以區塊鏈和金融科技為核心的鏈上金融生態平台。該平台將深度融合合規數字架構與傳統資產形態,系統推動資產的通證化、碎片化與跨境流動,打造高效、透明、互聯的新型金融基礎設施。在這一鏈上生態中,雙方將重點推動中國優質資產以合規及標準化方式"上鍊出海",通過創新產品設計、國際渠道共享與分佈式賬本技術,顯著提升中國資產的國際認可度和配置效率,拓寬境外資金參與路徑。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account